Literature DB >> 21334264

Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

Ahmed M Abu El-Asrar1, Sofie Struyf, Dustan Kangave, Saleh S Al-Obeidan, Ghislain Opdenakker, Karel Geboes, Jo Van Damme.   

Abstract

We assayed aqueous humor (AH) samples from patients with Behçet's disease (BD), Vogt-Koyanagi-Harada (VKH) disease, and HLA-B27-associated uveitis and control patients for the proinflammatory cytokines IL-15, IL-17, interferon-γ and tumor necrosis factor-α and the immunosuppressive cytokine IL-10. Cytokine levels were significantly higher in the three disease groups than in controls. In patients with similar disease activity, levels of IL-15 and IFN-γ were significantly higher in BD patients than in VKH and HLA-B27-associated uveitis groups. Logistic regression identified a significant negative correlation between BD and high levels of IL-10 and a significant positive correlation between VKH disease and high levels of IL-10. The proinflammatory cytokines versus IL-10 ratios were significantly higher in BD compared with other groups. These data suggest that both T helper (Th) 1 and Th17 cells are involved in endogenous uveitis immunopathogenesis. BD is characterized by extensive Th1 polarization, severe proinflammatory conditions and a low immunosuppressive status.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334264     DOI: 10.1016/j.clim.2011.01.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  62 in total

1.  Aqueous humor IL-8, IL-10, and VEGF levels in Fuchs' uveitis syndrome and Behçet's uveitis.

Authors:  Mert Simsek; Pinar Cakar Ozdal; Filiz Akbiyik; Mehmet Citirik; Nilufer Berker; Yasemin Ozdamar Erol; Pelin Yilmazbas
Journal:  Int Ophthalmol       Date:  2019-05-07       Impact factor: 2.031

2.  Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.

Authors:  Yong He; Cheng Huang; Bao-Ming Wu; Jun Li
Journal:  Rheumatol Int       Date:  2013-09-18       Impact factor: 2.631

Review 3.  IL-6 blockade in the management of non-infectious uveitis.

Authors:  Giuseppe Lopalco; Claudia Fabiani; Jurgen Sota; Orso Maria Lucherini; Gian Marco Tosi; Bruno Frediani; Florenzo Iannone; Mauro Galeazzi; Rossella Franceschini; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-20       Impact factor: 2.980

Review 4.  Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.

Authors:  Marko Barešić; Mirna Reihl; Mario Habek; Nenad Vukojević; Branimir Anić
Journal:  Rheumatol Int       Date:  2018-05-17       Impact factor: 2.631

5.  Activation of OX40 prolongs and exacerbates autoimmune experimental uveitis.

Authors:  Xiumei Wu; James T Rosenbaum; Grazyna Adamus; Gary L Zhang; Jie Duan; Andrew Weinberg; Zili Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

Review 6.  Behcet's disease with peripheral nervous system involvement successfully treated with golimumab: a case report and review of the literature.

Authors:  Menghui Yao; Congcong Gao; Chunyi Zhang; Xueqi Di; Wenfang Liang; Wenbo Sun; Qianqian Wang; Zhaohui Zheng
Journal:  Rheumatol Int       Date:  2020-07-16       Impact factor: 2.631

Review 7.  Cytokines in uveitis.

Authors:  Jessica E Weinstein; Kathryn L Pepple
Journal:  Curr Opin Ophthalmol       Date:  2018-05       Impact factor: 3.761

8.  Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis.

Authors:  Alejandra de-la-Torre; Alexander W Pfaff; Michael E Grigg; Odile Villard; Ermanno Candolfi; Jorge E Gomez-Marin
Journal:  Cytokine       Date:  2014-04-16       Impact factor: 3.861

9.  [Clinical analysis of golimumab in the treatment of severe/refractory cardiovascular involvement in Behcet syndrome].

Authors:  L X Sun; J J Liu; Y X Hou; C R Li; L Li; X P Tian; X F Zeng; W J Zheng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

10.  Immunological and pathological investigations in equine experimental uveitis.

Authors:  Galina P Simeonova; Svetozar Z Krastev; Radostin S Simeonov
Journal:  Vet Res Commun       Date:  2016-06-25       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.